Codexis

Codexis, Inc. is an industrial biotechnology company that specializes in the engineering of enzymes for pharmaceutical and chemical production through biocatalysis. Established in 2002 and headquartered in Redwood City, California, Codexis develops and sells protein catalysts and intermediate chemical products, as well as offering protein catalyst screening and engineering services. The company employs its proprietary CodeEvolver technology platform, which facilitates enzyme optimization by introducing genetic mutations into microorganisms. This platform is utilized by over 50 pharmaceutical manufacturers globally to enhance their process development and manufacturing efficiency. Codexis generates most of its revenue through product sales and also licenses its technology to enable clients to engineer enzymes for their own applications. Its customer base spans various regions, including the United States, Europe, and parts of Asia.

John Nicols

President and CEO

Rob Wilson

SVP and General Manager, Performance Enzymes

3 past transactions

seqWell

Series C in 2022
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory services. It features a technology platform that serves as a transformative library prep technology that allows for simple, scalable multiplexing of 100s to 1000s of samples without time- and cost-consuming normalization. The company was founded in 2014 and headquartered in Massachusetts, United States.

Molecular Assemblies

Series B in 2022
Molecular Assemblies, Inc. is a San Diego-based company specializing in enzymatic DNA synthesis technology, which facilitates the development of DNA-based products across various industries. Founded in 2013, the company focuses on creating long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner, inspired by natural processes. Its technology has applications in industrial synthetic biology, personalized therapeutics, precision diagnostics, information storage, nanotechnology, and DNA electronics. The firm boasts a skilled executive and scientific team, supported by a robust intellectual property portfolio. Molecular Assemblies has garnered investments from a range of venture capital sources, indicating strong interest in its innovative approach to DNA synthesis.

Molecular Assemblies

Series A in 2021
Molecular Assemblies, Inc. is a San Diego-based company specializing in enzymatic DNA synthesis technology, which facilitates the development of DNA-based products across various industries. Founded in 2013, the company focuses on creating long, high-quality, sequence-specific DNA in a reliable, affordable, and sustainable manner, inspired by natural processes. Its technology has applications in industrial synthetic biology, personalized therapeutics, precision diagnostics, information storage, nanotechnology, and DNA electronics. The firm boasts a skilled executive and scientific team, supported by a robust intellectual property portfolio. Molecular Assemblies has garnered investments from a range of venture capital sources, indicating strong interest in its innovative approach to DNA synthesis.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.